The UK’s NICE recently condemned the use of many drugs for chronic primary pain due to their limited benefit and potential to cause very real harm. Instead, the regulator recommended...
GlobalData research has found the biggest influencers in healthtech based on their performance and engagement online. Using research from GlobalData’s…
Pfizer and BioNTech are set to submit an application to the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of their mRNA…
Mesoblast and Novartis have signed an exclusive agreement for the development, manufacture and commercialisation of the former’s mesenchymal stromal cell (MSC) product remestemcel-L. Remestemcel-L is…
The US Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) to Regeneron Pharmaceuticals’ antibody cocktail casirivimab and…
The UK's Imperial College London has reported that early data from the REMAP-CAP trial showed Roche's arthritis drug, Actemra (tocilizumab),…
The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for Eli Lilly and Company and…
AstraZeneca and Oxford University’s late-stage trial has showed that their Covid-19 vaccine candidate, ChAdOx1 nCoV-19, induced a strong immune response…
On 16 November, results from the randomised, double-blind, placebo-controlled FIDELIO-DKD trial were presented at the Annual Scientific Sessions of the American Heart Association (AHA). They demonstrated that Bayer’s finerenone, a…
An association has been recognised between Covid-19 infection and cardiovascular disease (CVD) since the early weeks of the pandemic. Covid-19 patients with pre-existing CVD have a poorer prognosis compared to…
Lack of availability of effective treatment options and associated high unmet need in pancreatic cancer has warranted focused research on identifying a novel mechanism of actions for treating patients in…
From new details about the EU's Digital Services Act to the biggest govtech deals of the past few days, here...
From the EU's war on encryption to Facebook's threat to pull out of Europe, here are the key developments from this week.
From 'Europe's digital decade', to the $40bn sale of ARM, here are the key developments so far this week. NS Tech reports.
From AWS’s fury over Microsoft’s $10bn Pentagon cloud deal, to a new £50m fund for AI-powered healthcare products, Oscar Williams finds the five key developments...
Customised Viral Vectors for Cell Modelling, Gene Therapy, and Vaccination Research and Development
Biggest influencers in healthtech in Q3 2020: The top individuals to follow
GlobalData research has found the biggest influencers in healthtech based on their performance and engagement online. Using research from GlobalData’s Influencer platform, Pharmaceutical Technology has named the most influential people…